Horizon Pharma plc Announces Third-Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Paradium AI (PAAI) Halted, News Pending
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Horizon Pharma (HZNP) PT Lifted to $30 at Mizuho
November 8, 2016 6:17 AM ESTMizuho Securities analyst Irina Koffler reiterated a Buy rating and bumped her price target on Horizon Pharma (NASDAQ: HZNP) to $30.00 (from $29.00) following solid Q3 results and strong rebound in the stock.
Koffler commented, "HZNP had a strong move after 3Q:16, rebounding from the... More
